| CYSB2101052 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-04-27 | | Gan & Lee Pharmaceuticals | | | view |
| AS20000032 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | New Drug Application | 2000-10-31 | 安万特（中国）投资有限公司 | Sanofi (China) Investment Co Ltd | Approval Completed-Pending Certificated | | view |
| CXSS2200079 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | New Drug Application | 2022-09-17 | | Hefei Tianmai BIOTECHNOLOGY Development Co Ltd | | | view |
| CYSB2400040 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-02-09 | | Gan & Lee Pharmaceuticals | | | view |
| JXSS2200043 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Import Drug Application | 2022-12-27 | | | | | view |
| CYSB2400140 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2101100 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-06-21 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2300079 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-04-05 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400041 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-02-09 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2101083 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-06-03 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| JYSB2101114 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-08-26 | | Sanofi-Aventis Deutschland GmbH | | | view |
| CYSB2400141 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2101250 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-11-03 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| CYSB2200121 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2022-05-18 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2300078 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-04-05 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2300211 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2023-11-22 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| CYSB2101082 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-06-03 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| CYSB2400113 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2024-05-14 | | Wanbang Biopharmaceuticals | | | view |
| CYSB2101051 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-04-27 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2101251 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2021-11-03 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
